View in EDS HTML Full Text PDF Full Text

HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19.

Saved in:
Bibliographic Details
Title: HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19.
Authors: Astbury, Stuart1,2 (AUTHOR), Reynolds, Catherine J.3 (AUTHOR), Butler, David K.3 (AUTHOR), Muñoz‐Sandoval, Diana C.3 (AUTHOR), Lin, Kai‐Min3 (AUTHOR), Pieper, Franziska P.3 (AUTHOR), Otter, Ashley4 (AUTHOR), Kouraki, Afroditi5 (AUTHOR), Cusin, Lola6 (AUTHOR), Nightingale, Jessica5 (AUTHOR), Vijay, Amrita5 (AUTHOR), Craxford, Simon5 (AUTHOR), Aithal, Guruprasad P.1,2 (AUTHOR), Tighe, Patrick J.6 (AUTHOR), Gibbons, Joseph M.7 (AUTHOR), Pade, Corinna7 (AUTHOR), Joy, George8 (AUTHOR), Maini, Mala9 (AUTHOR), Chain, Benny9 (AUTHOR), Semper, Amanda4 (AUTHOR)
Source: Immunology. May2022, Vol. 166 Issue 1, p68-77. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00192805
DOI:10.1111/imm.13450